TemplatesType: Form/Template8 min readUpdated May 2026By Julian Vance

Letter of Intent Sample for FDA

Having a well-structured letter of intent sample for fda is the single most important step you can take to ensure consistency, reduce errors, and save countless hours. Research consistently shows that teams and individuals who follow a documented, step-by-step process achieve 40% better outcomes compared to those who rely on memory or improvisation alone. Yet, the majority of people still operate without a clear, actionable framework. This comprehensive Letter of Intent Sample for FDA template bridges that gap — giving you a battle-tested, ready-to-use guide that covers every critical step from start to finish, so nothing falls through the cracks.

What is a Letter of Intent Sample for FDA?

A letter of intent sample for fda is a standardized document used to streamline processes, ensure consistency, and maintain compliance within the domain. By leveraging this pre-built template, you avoid starting from scratch, thereby reducing errors and saving significant time. Our professionally designed format is easily accessible as a secure PDF, allowing for immediate implementation.

Complete Document Preview

Template Registry

Standard Operating Procedure

Registry ID: TR-LETTER-O

LETTER OF INTENT (LOI) FOR FDA REGULATORY SUBMISSION

Document ID: TR-8829-FDA
Effective Date: [____/____/2026]

Instructions for Use

Authorized Preparer: This document must be executed by the Regulatory Affairs Officer, Chief Scientific Officer, or legal equivalent of the Sponsor/Applicant.
Filing & Retention: Upon transmission to the FDA, file a copy in the electronic Common Technical Document (eCTD) repository. Retain the original signed copy in the corporate Quality Management System (QMS) for a minimum of 7 years post-market withdrawal.
Mandatory Attachments: Ensure this LOI is accompanied by the relevant cover letter, executive summary of the regulatory pathway, and proof of user fee payment (if applicable).

I. APPLICANT INFORMATION

Company Name: [__________]
Address: [__________]
FDA Registration Number (FEI): [__________]
Regulatory Contact Person: [__________]
Contact Email: [__________]

II. SUBMISSION CLASSIFICATION

Submission Type:
[ ] Pre-Market Notification (510(k))
[ ] Pre-Market Approval (PMA)
[ ] De Novo Classification Request
[ ] Investigational New Drug (IND)
[ ] Biologics License Application (BLA)
[ ] Other: [__________]

III. PRODUCT/DRUG IDENTIFICATION

Product/Device Common Name: [__________]
Proprietary/Trade Name: [__________]
Intended Use/Indications:
[Provide a concise 2-3 sentence description of the medical purpose of the product]
[__________________________________________________]

Classification Panel/Division: [__________]

IV. REGULATORY INTENT & RATIONALE

Proposed Regulatory Pathway: [__________]
Predicate/Reference Device/Drug: [__________]
Anticipated Filing Date: [____/____/2026]

Brief Rationale for Submission:

[Describe the primary objective of this submission]
[Specify any prior FDA interaction or Pre-Sub meeting reference]
[List the primary clinical/technical evidence to be presented]

V. CERTIFICATION AND WARRANTIES

The undersigned, acting as the authorized representative of [__________] (the "Company"), hereby confirms:

That all data provided in support of the forthcoming regulatory submission is true, accurate, and complete to the best of our knowledge.
That the Company is in full compliance with current Good Manufacturing Practices (cGMP) or Good Clinical Practices (GCP) as applicable.
That the Company agrees to provide all requested supplementary information required by the FDA during the review cycle in a timely manner.

VI. EXECUTION

Authorized Signature: ___________________________
Printed Name: [__________]
Title: [__________]
Date: [____/____/2026]

Disclaimer: This document is provided as a standardized framework. Consult qualified legal counsel for jurisdiction-specific statutory compliance.

Official Standardized Document

Download this Template

View all